Raymond T. Bartus
Affiliations: | Ceregene |
Area:
neurodegenerative diseases, translational R&D, neurotrophic factors, gene transferGoogle:
"Raymond Bartus"Mean distance: 106866
Collaborators
Sign in to add collaboratorRolf F. Barth | collaborator | ||
Eugene P Brandon | collaborator | ||
Raymond S. Dean | collaborator | ||
Steve H. Ferris | collaborator | ||
Mark A. Stacy | collaborator | ||
John G. Marriott | collaborator | 1974-1979 | Parke-Davis Pharmaceuticals |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chu Y, Bartus RT, Manfredsson FP, et al. (2020) Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease. Brain : a Journal of Neurology. 143: 960-975 |
Gross SK, Shim BS, Bartus RT, et al. (2019) Focal and dose-dependent neuroprotection in ALS mice following AAV2-neurturin delivery. Experimental Neurology. 113091 |
Bartus RT, Johnson EM. (2016) Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned? Neurobiology of Disease |
Bartus RT, Johnson EM. (2016) Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next? Neurobiology of Disease |
Marks WJ, Baumann TL, Bartus RT. (2016) Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer. Human Gene Therapy. 27: 522-7 |
Olanow CW, Bartus RT, Volpicelli-Daley LA, et al. (2015) Trophic factors for Parkinson's disease: To live or let die. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1715-24 |
Warren Olanow C, Bartus RT, Baumann TL, et al. (2015) Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Annals of Neurology. 78: 248-57 |
Bartus RT, Kordower JH, Johnson EM, et al. (2015) Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies. Neurobiology of Disease. 78: 162-71 |
Rafii MS, Baumann TL, Bakay RA, et al. (2014) A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 571-81 |
Bartus RT, Weinberg MS, Samulski RJ. (2014) Parkinson's disease gene therapy: success by design meets failure by efficacy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 487-97 |